4.7 Article

Critically ill patients with COVID-19 show lung fungal dysbiosis with re duce d microbial diversity in patients colonized with Candida spp.

Journal

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 117, Issue -, Pages 233-240

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2022.02.011

Keywords

COVID-19; NGS; Next-generation sequencing; ARDS; Acute respiratory disease syndrome; Dysbiosis; Mycobiome

Ask authors/readers for more resources

This study aimed to compare the lower respiratory tract mycobiome of critically ill patients with COVID-19 to patients without COVID-19 pneumonia. The results showed that COVID-19 patients were more likely to be colonized with Candida spp., and ARDS was associated with lung dysbiosis.
Background: The COVID-19 pandemic has intensified interest in how the infection affects the lung microbiome of critically ill patients and how it contributes to acute respiratory distress syndrome (ARDS). We aimed to characterize the lower respiratory tract mycobiome of critically ill patients with COVID-19 in comparison to patients without COVID-19. Methods: We performed an internal transcribed spacer 2 (ITS2) profiling with the Illumina MiSeq platform on 26 respiratory specimens from patients with COVID-19 as well as from 26 patients with non- COVID-19 pneumonia. Results: Patients with COVID-19 were more likely to be colonized with Candida spp. ARDS was associated with lung dysbiosis characterized by a shift to Candida species colonization and a decrease of fungal diversity. We also observed higher bacterial phylogenetic distance among taxa in colonized patients with COVID-19. In patients with COVID-19 not colonized with Candida spp., ITS2 amplicon sequencing revealed an increase of Ascomycota unassigned spp. and 1 Aspergillus spp.-positive specimen. In addition, we found that corticosteroid therapy was frequently associated with positive Galactomannan cell wall component of Aspergillus spp. among patients with COVID-19. Conclusion: Our study underpins that ARDS in patients with COVID-19 is associated with lung dysbiosis and that an increased density of Ascomycota unassigned spp. is present in patients not colonized with Candida spp. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available